Literature DB >> 25343488

Factors associated with early mortality after living-donor liver transplant.

Chuan Li1, Tian-Fu Wen, Lu-Nan Yan, Bo Li, Jia-Ying Yang, Wen-Tao Wang, Ming-Qing Xu, Yong-Gang Wei.   

Abstract

OBJECTIVES: We sought to identify the risk factors associated with the early mortality after a living-donor liver transplant.
MATERIALS AND METHODS: Two hundred eighteen patients were recruited in this study. Potential risk factors were analyzed using univariate and multivariate analyses. A C statistic equivalent to the area under the receiver operating characteristic curve was used to assess the ability of the model to predict mortality risk during the first 3 months after a living-donor liver transplant.
RESULTS: Twenty-six recipients died within the first 3 months after a living-donor liver transplant. On a multivariate analysis, intraoperative allogeneic red blood cell transfusion and the preoperative creatinine levels were independently associated with early postoperative mortality. A prognostic model was proposed in this study (early mortality risk score = 0.107 × intraoperative allogeneic red blood cells transfusion [U] + 0.005 × preoperative creatinine concentration [μmol/L]). Three-month survival rates of patients with high and low scores were 69.8% and 95.5% (P < .001).
CONCLUSIONS: Transfusion of intraoperative allogeneic red blood cell and preoperative creatinine levels are associated with the early mortality after living-donor liver transplant. A model to predict early mortality after a living-donor liver transplant based on these risk factors was proposed in this study.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25343488     DOI: 10.6002/ect.2014.0031

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  1 in total

1.  Extensive Adhesions in Living Donor Liver Transplantation: A Retrospective Analysis.

Authors:  Hirak Pahari; Wei-Feng Li; Tsan-Shiun Lin; Chih-Chi Wang; Chee-Chien Yong; Ting-Lung Lin; Chih-Che Lin; Yueh-Wei Liu; Yu-Hung Lin; Allan M Concejero; Bruno Jawan; Chao-Long Chen
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.